The pro-inflammatory cytokine IL-1β could increase extracellular levels of serotonin in the brain as well as serotonin transporter (SERT) activity, which may reflect a coordinated serotonergic response to immune activation, and disruption of this homeostatic mechanism may be a risk for diseases such as depression or autism [57]. The gene discussed is IL1B; the disease is depressive symptom measurement.